Liverpool pupils blast off for special book reading

Liverpool schoolchildren were treated to a sneak preview of a new science and innovation story based here in the city.

Pupils from LIPA Primary School listened intently as author Natalie Reeves-Billing read Animates Liverpool, a tale of a team of seven animal inventors who crash land in the Knowledge Quarter Liverpool innovation district and embark on an adventure to explore the different innovations that will get them back into space.

They then enjoyed a fun drawing and creative design workshop, hosted by illustrator Stuart Harrison, at John Lewis department store in Liverpool One.

The book, created by KQ Liverpool under exclusive licence with Connected Places Catapult, is designed to introduce young children to the concept of innovation and inspire them to understand the various science, technology and innovation careers on their doorstep.

Rachael Stevens, head of partnerships at Knowledge Quarter Liverpool, said:

“Animates Liverpool is a unique way of engaging young children in the ideas of invention and creativity. Knowledge Quarter Liverpool abounds with bright minds making incredible discoveries and we hope the book allows them to see what their own future might hold.

“The children had a great time hearing all about the adventures of the Animates in their home city and creating their own versions of Bam Bamboo, the space panda. It was wonderful to see the spark of innovation coming to life in a new generation of pioneers.

New £1.5 million novel technologies initiative launches to accelerate new approaches to infection transmission

Companies and research groups with novel solutions to tackle infection transmission will have the opportunity to shape the direction of the UK’s infection response and bid for funding through a new initiative to stimulate innovation.

The Infection Innovation Consortium: iiCON, a consortium led by Liverpool School of Tropical Medicine, has been appointed by UK Research and Innovation (UKRI) to deliver the new project.

The consortium will bring together and support the formation of diverse cross-disciplinary networks to propel the development of new concepts and solutions that leverage disruptive technologies such as Artificial Intelligence (AI), digital and automation, advanced humanised infection models, and novel diagnostics to combat the spread of infection.

Professor Janet Hemingway, founding director of iiCON, said:

“Combatting the transmission of infection is one of the key health challenges of our time, and one that is growing in urgency. As such, it’s critical that we leverage novel, disruptive technology to drive forward our collective efforts to tackle the spread of infection. We are particularly keen to engage individuals and companies who have not previously worked in this area.

“We hope this exciting programme will spark the formation of new cross-disciplinary networks and support participants to shape the future direction of our response to infection transmission – bringing forward novel concepts and approaches that may hold the key to unlocking this critical issue.”

 

Companies and groups will have the opportunity to apply to take part in two ‘sandpit’ events held in Liverpool on March 14th and London on May 9th. These intensive innovation workshop sessions will help to spark ideas, foster innovation, and create new collaborative approaches to tackle this urgent challenge and drive forward novel projects.

Complementing the work of UKRI’s flagship AMR and epidemic preparedness programmes, the sandpits will look to pump-prime radical new approaches to tackling infections by engaging new communities and capabilities with the challenge.

The programme is supported with £1.5 million funding from UKRI to bring new research communities together and support feasibility studies. The sandpits will shape the call for funding pots of £50,000 to £150,000 to test disruptive approaches to tackling infections. Network support grants of up to £50,000 will also be available.

The development of new antibiotics and companion diagnostics are out of scope for the new fund, as these are covered by the recently announced PACE initiative.

To find out more and register interest in taking part in the sandpit events being held in March and May, please visit: www.infectioninnovation.com/ukri-sandpit

The Pandemic Institute showcases achievements to philanthropic donor

The Pandemic Institute has welcomed a visit from Dr Charles Huang, whose company Innova Medical Group provided the initial £10m philanthropic donation that founded the Institute. Launched in 2021, The Pandemic Institute is a unique collaboration of academic, health and civic partners, whose mission is to tackle emerging infections and future pandemic threats.

Liverpool was chosen to be the home of The Pandemic Institute thanks to its unique ecosystem, hosting medical, veterinary, public health, tropical medicine and behavioural science schools and institutes. Liverpool has an unrivalled breadth of world-leading clinical and academic expertise in the areas required to deliver an end-to-end response to the challenge of emerging infections and future pandemics, all co-located in one city. During the COVID-19 pandemic, Liverpool pioneered innovative approaches including a whole city community testing pilot which cut transmission rates by a fifth, as well as hosting large-scale pilot events on behalf of the Government that provided evidence of how to safely reopen important sectors of the economy – developing Liverpool’s reputation as a leader in pandemic management and resilience.

The Pandemic Institute also builds on Liverpool’s work leading the National Institute for Health and Care Research (NIHR) Health Protection Research Unit in Emerging and Zoonotic Infections (since 2014) which was at the forefront of the UK research response to Ebola, Zika and Covid-19. During the visit, the team at TPI were proud to showcase some of the things the institute has achieved since it’s formation, including identifying and funding high priority research during the MPox outbreak, establishing a £5M research partnership with Seqirus – a global leader in influenza, and more recently providing funding to employ key research or technical staff who will carry out a range of pandemic preparedness projects, and be ready to pivot to respond rapidly against any new threat that arises. The Pandemic Institute also manages the UK Pandemic Sciences Network, which brings together the UK’s leading pandemic science research teams to support the delivery of the G7’s 100 Days Mission.

As part of his visit, Dr Huang joined TPI director Professor Tom Solomon who was hosting a session on ‘preparing for future pandemics’ at The Royal Society Creating Connections event. He also joined members of the TPI team for a tour of some of the fantastic facilities Liverpool has to offer including the Digital Innovation Facility, the infectious diseases labs at University of Liverpool, the NIHR Clinical Research Facility at the Liverpool University Hospitals NHS Foundation Trust, and the Accelerator Research Clinic at the Liverpool School of Tropical Medicine.

“I’m delighted to visit my PhD mentor Professor Steven Young’s Alma mater – the University of Liverpool – and The Pandemic Institute, and hear about the Institute’s work and progress. Now with Innova Nanojet Technologies’ award winning and breakthrough product that can effectively and efficiently remove airborne viruses, pollens and pollutants, we are now in a position to continue to support the Institute, the University of Liverpool and the city of Liverpool to remain at the forefront of combatting pandemics”.

Dr. Huang is the founder and chairman of Pasaca Capital Inc., who own Innova Medical Group, he founded the Charles Huang Foundation in 2020, looking for meaningful ways to give back to society and help others.

Professor Tom Solomon CBE, from the University of Liverpool’s Infection, Veterinary and Ecological Sciences Institute, and Director of The Pandemic Institute said:

“It’s been wonderful to host Charles in Liverpool, and show him just some of the work we have been doing supported by his initial investment.”

Learn more about the work of The Pandemic Institute and the founding partners here.

The future is Fabric District

A new prospectus has been released showcasing the future vision for Fabric District, a key component of Liverpool’s Knowledge Quarter.

The document, created by Fabric District CIC, sets out how the once thriving area is set to become a resurgent force in the city’s economy, retaining the strengths of its existing community and welcoming new residents, businesses and visitors.

Its vision includes enhancing the public realm to prioritise pedestrians and cyclists over motor vehicles, bringing vacant sites and buildings back into use, especially at street level, encouraging vibrant street activity and appropriate new developments, including affordable accommodation, while helping to create new start-up and employment opportunities.

Fabric District CIC is working closely with Liverpool City Council and Knowledge Quarter Liverpool to drive forward a long-term, community-led regeneration strategy.

In his opening remarks of the prospectus, Michael Birkett, chair of Fabric District CIC, says:

“The Fabric District will regain its status as a vibrant part of Liverpool City Centre.”

The prospectus describes the potential of Fabric District:

“The Fabric District connects the cultural heart of the city with the University campuses and the ‘centre of knowledge’…[It] has the absolute potential to reverse its fortunes. Many ‘green shoots’ have already appeared.”

Colin Sinclair, chief executive of Knowledge Quarter Liverpool, adds:

“As a key area within KQ Liverpool, the Fabric District will play a crucial part in the ongoing economic growth and prosperity within our innovation district. Attracting additional public and private sector investment to help regenerate the area will provide further stimulus to support the great progress made to date.”

The new prospectus can be found here.

 

 

 

Job vacancies across KQ Liverpool

Have you been considering getting a new job for the new year?
Interested to see what exciting career opportunities are available within our innovation district?

There are a whole host of fantastic roles currently being advertised by KQ Liverpool partners and the individual businesses who are located within our urban innovation district, ranging from senior positions to entry level opportunities.

Jobs currently being advertised include roles at the Liverpool School of Tropical Medicine, The Pandemic Institute, Spaces at The Spine, Virtual Engineering Centre, The Brain Charity, Angel Solutions and the MTC.

Current vacancies include:

  • Head of Innovation Capacity Strengthening (FLIGHT Programme)
  • Digital Artist (3D Modelling, Animation, Design & UX)
  • Event Manager
  • Junior Automation Test Engineer
  • Future Skills Advisor
  • Physiotherapist

Further details for each role including job descriptions, role requirements and application deadlines can be found in the below links:

LSTM
Various roles (15)
Apply here

 

The Pandemic Institute
Project Co-Ordinator
Apply here

 

Spaces at The Spine
Event Manager
Apply here


The Brain Charity
Various roles:

  • Executive Assistant to the CEO
  • Information and Advice Officer
  • Physiotherapist
  • Social Connector

Apply here

 

Virtual Engineering Centre
Various roles:

  • Digital Artist (3D Modelling, Animation, Design & UX)
  • Serious Games Developer (Unreal Engine)
  • Data Scientist
  • Technical Specialist (IoT & Systems Engineering)
  • Full Stack Developer – *available to apply for soon.
  • Project Engineer (3D Environments, Reality Capture & Scanning Technologies) 
  • Data Science and Software Engineer (Generic Algorithms)

Apply here


Angel Solutions
Various roles:

  • Strategic Account Manager (Multi-Academy Trusts)
  • Account Manager
  • Junior Automation Test Engineer
  • User Interface Designer

Apply here

MTC
Various roles:

  • Project Manager – Large Programmes
  • Assistant Project Manager – Large Programmes
  • Programme Manager – Large Programmes
  • Future Skills Advisor x2

Apply here

 

Please note – Application deadlines vary, with some closing on Monday 15th January 2024. 

What next for KQ Liverpool after Investment Zones? 

What next for KQ Liverpool after Investment Zones?

What will Liverpool look like post Investment Zone funding?

Are Investment Zones a one off or is this an opportunity to build on what could be achieved in the next five years? 

Introduction

In the Spring Budget, a refocused Investment Zone programme was announced that will see the creation of 12 Investment Zones across the UK. This includes a health and life sciences Investment Zone in Liverpool City Region, with a package of £80m funding over the next five years. 

With a general election upcoming and Investment Zone delivery due to commence in April next year, Knowledge Quarter Liverpool (KQ Liverpool) held a roundtable with some of its key innovation district stakeholders, to consider what’s next for KQ Liverpool and Liverpool City Region in the years to come. 

So what does the future look like for KQ Liverpool, the City and the City Region? The below write-up shares an insight into some of the main discussion points and priorities covered during the event, along with some recommendations, shared visions and overarching sentiments for the future.

 

Asset-based clusters

Following an initial welcome by KQ Liverpool CEO, Colin Sinclair, who Chaired the debate, then opened the discussion to the room, starting with a question around asset-based cluster development and why it is important to the future development of Liverpool City Region. 

In response, Professor Matt Reed, Strategic Director of the University of Liverpool’s Materials Innovation Factory, started by saying: “Asset based clusters can have a powerful effect. There is evidence to prove that organically grouped people and high density clustering of knowledge assets drives the economy. I would also suggest that we all need to look granularly at our growth trajectory and engage more with the outside world.”

Professor Janet Hemmingway, Founding Director of iiCON, agreed by saying: “We have got the set-up to be a global power, thanks to our existing industry, academia and NHS supercluster. This is starting to work and the consortium’s effort is delivering real life impact and leveraging new products.” She advised that: “We are still too academic in our approach however, and we need to strengthen our industrial base to leverage further activities in exporting and high value jobs for LCR.”

 

Civic Data

Following on from this, the conversation turned to why civic data and mental health is so important to inclusive innovation, and how local projects in this field can create global collaborations and encourage new occupiers to cluster in KQ Liverpool.

Professor Iain Buchan, Associate Pro Vice Chancellor for Innovation at University of Liverpool, said: “There is a social impact culture in Liverpool where people swarm if they believe in what they are doing. The Covid-19 pandemic saw people put organisational barriers aside and share data for the greater good. Liverpool gets the job done, and like tonight, gets people in the room who can make things happen.”

Professor Raphaela Kane, Pro Vice Chancellor – Faculty of Health at Liverpool John Moores University, added: “The healthcare workforce needs to ensure they have the right skills for the future and we need to think beyond traditional silos for healthcare delivery. A ‘grow our own’ philosophy will make a significant local impact for employment and health outcomes, as well as attracting the right people in.”

 

Global reach and scale

The next topic discussed was in relation to ensuring that the projects being brought forward under the Investment Zone also have a global reach and impact. 

Providing this international viewpoint was Professor David Lalloo, Director at LSTM, who explained: “LSTM’s focus is predominantly outside of the UK, but its work is relevant to the UK. We are seeing a huge change in countries becoming more wealthy thanks to an explosion of innovation. We need a long term strategy, as funding for global health is changing, and learn from global best practice.”

Dr Carol Costello, Chair of KQ Liverpool and Director of People and Services at the University of Liverpool, added: “We have a network of alumni around the world which provides a huge database that we don’t use as much as we should. We need to think more practically and maximise where there are interrelations that we can join up and benefit from.”

With regards to inward investment, Professor Mark Power, Chair of Sciontec Developments Limited, and Vice-Chancellor and Chief Executive of Liverpool John Moores University, explained: “We don’t have sufficient large scale employers in LCR, but we do have a huge talent pipeline that has business ideas, but these will only form part of the supply chain. We need to identify where there is space for the bigger organisations to come in, as well as growing existing KQ Liverpool based companies. The challenge is selling the LCR lifestyle and incubation space, as we have the ambition to do it, so collectively we can offer a menu of opportunities.”

 

Commercial investment

Adding to the discussions regarding work space provision and commercial investment into LCR, Andrew Lewis, incoming Chair of KQ Liverpool and Chief Executive of Liverpool City Council, said: “I have been struck by the number of assets in Liverpool City Region, and the concentration of them in KQ Liverpool. We have a big obligation to master plan the estate, as space is precious and not surplus. The Investment Zone has taken opportunities locally and created a network of capabilities which is quite profound, and will attract further attention in the coming years. 

“Hosting Eurovision demonstrated how Liverpool’s international brand is real and not just a perception. Referring to social impact, the role of The Pandemic Institute and businesses being attracted here is great, and we’re also attracting students and educating them who will then go into the world of work. It is important but there are massive shortages. 

“We have excelled on the academic side, and we now need to nurture commercial indigenous growth from academics and students creating new businesses, and also attracting inward investment. LCC is now making stronger capabilities and connections with the Combined Authorities, creating a stronger ‘to do’ list. It is great to hear the optimism in the room.”

 

National outlook

Giving a wider view of Liverpool City Region’s capabilities was Sean Davis, Finance Director – Investments at Bruntwood, who said: “From a national perspective, regeneration and the growth of clusters doesn’t happen overnight. Liverpool has to identify its unique set of strengths, which it is already doing, but also needs to try and get investment out of the golden triangle and develop stronger relationships.”

Sally Bloor, Head of Marketing and Communications at Sciontec, agreed and added: “We’re currently aware of a big lab space enquiry and are working on a bespoke pack for this. I think we’re three quarters of the way there in attracting large occupiers, but there is more to be done to refine the micro detail of our offer, in terms of available buildings, their specific location, plus access to R&D and talent. We have worked closely with Growth Platform and have linked up with the KQ Liverpool based Universities to make stronger messaging which is helping. Similarly with attracting Cashplus Bank, colleagues from LJMU, UoL, and the City Council helped pitch directly to them, so I think this type of leveraging should be undertaken more often.”

 

Communication, collaboration and skills

Further to Sally’s recommendation to refine our offer, Dr Charlie Whitford, Director of Regional Strategy & Engagement at The Manufacturing Technology Centre (MTC), echoed this sentiment by saying: “We need to keep the messaging simple when we’re communicating the story of superclusters. The Investment Zone is commendable, with the capabilities coming together for the greater good, which is greater than the individual parts.” 

He also discussed the role of local infrastructure by saying: “People who are looking to relocate place a key focus on the cultural environment in which they’re going to work. As such, the transport in LCR needs to be better, because the city will become clogged if we continue to expand at the same pace. We’re also experiencing a ‘tale of two cities’, as the north of Liverpool needs more development, and we need a positive approach to not being too localised with politics.”

The MTC is a High Value Manufacturing Catapult (HVMC), whose Digital Manufacturing Accelerator is located within Liverpool Science Park (LSP). Another HVMC Centre based at LSP is CPI, and their Strategic Partnerships Manager for the North West, Damian Mohammed, added: “The key challenge we are solving is leveraging public funding to unlock private investment, to ensure projects have longevity and legacy. Having both a commercial focus with social impact makes a real difference, ensuring inclusive innovation. We are working with academic, industry and government-funded stakeholders in the region to help deliver this. We do, however, need to consider how the new Investment Zone projects will find the talent needed to deliver their impact, and we are working with the region to identify the skills of the future. We need to start working with schools, colleges and universities now, to develop STEM skills for the next 5-10 years.”

 

Workspaces of the future

Aligned with the future vision theme, Leanne Katsande, Head of Commercial at Sciontec, shared how “Space requirements have gone full circle, and lab occupier demand has grown significantly. Flexibility is essential and all of our developments will be futureproofed for occupiers so we can accommodate ongoing enquiries.”

Architectural practice, Fairhursts Design Group, have been behind some of the largest and most innovative lab schemes in the UK. When asked about how KQ Liverpool could differentiate and future proof new lab schemes, Laura Sherliker, Director at The Fairhursts Design Group, explained: “Labs requirements are ever changing, although building stock is finite. We need to make buildings not monuments, and civic architecture needs to be for locals and not contain any social barriers. For this, we must link up with schools and other groups in the community. Having the right strategy and vision is so important, so we need to consider how buildings will change in the next 5-10 years. I think smaller, tech enabled labs will be more in demand, although these use a lot of energy, so we need to set a sustainability agenda now and continuously strive for better standards.”

Rob Hopkins, Director at AHR (who was the lead architect when designing The Spine in Paddington Village), offered an additional view point, saying: “With regards to innovative workspaces of the future, we can no longer detach living and work spaces. We need to have the confidence to bring together both elements at Paddington Village, and we have a great opportunity to do it first and to do it best. What has been done at The Spine can be done with living spaces, as well as other workspaces.” He also added: “KQ Liverpool has the ability to bring all of the right ingredients together. Occupiers want the greatest place and environment for their workforce to thrive. We should think cleverly about existing spaces too and use what we’ve got.”

 

Living labs

Lorna Green, CEO of LYVA Labs explained that: “We have already seen the benefits of flexible work space and connectivity for our own company, and as a result of the investment we’re putting into creating new companies in the region, they will need somewhere to locate. The LCR Investment Zone means that we can run this additional accelerator space.”

She also set an interesting challenge for participants to consider. “After Investment Zones, I’d like to turn LCR into a living lab for healthcare. We can’t underestimate the importance of wrap-around support for startups, and we have got so many of the other building blocks already, like knowledge assets, data, and training. Through this support, businesses can then turn into innovators and scale.”

“Bring it on!” was the immediate response from Jan Ledward, Director of Strategy and Partnerships at Liverpool University Hospitals NHS Foundation Trust. “A living lab would provide a combination of mental and physical health solutions within a care environment. We should also create doctors of the future who have a wider view of conditions, although we really need these skills now, not 5 years in the future.”

 

Partnerships and talent retention

Professor Tom Solomon, Director of The Pandemic Institute, discussed the benefits of partnerships, by saying: “I’d like to see more conversations about commerce, not academia, although we have a strength in joining them up through The Pandemic Institute, the city council and higher education partners. International partners have also been built up over many years and a recent visit to Bangalore has led to an exciting new partnership, but there were no council or commercial delegates on the trip, which I think was a missed opportunity.”

Linking back to Professor Mark Power’s point, Tom added: “Big companies have looked at locating within LCR, but they didn’t actually land here. We should have a drive to try and build new facilities, like our proposed pandemic preparedness and response laboratories, so that we can attract and accommodate these larger enquiries.”

Addressing the group next from KQ Liverpool’s perspective, was Rachael Stevens, Head of Partnerships and External Relations, who said: “The Investment Zone presents an opportunity for projects to happen, but we need to focus on bringing a spatial focus together to promote it externally. We can also use the Investment Zone as a way to attract graduate talent, but we need skills and mid management roles for the 25-40 year old workforce, as this is where we are losing people to other cities.”

 

Optimism for the future

To summarise the Roundtable, Andrew Lewis, incoming Chair of KQ Liverpool, said: “I’d like to end on a note of optimism and self confidence about our future. We’re all aware of the gaps we’re facing and when we put the table of points together, we get a platform for growth. Where we are now is incredibly powerful. We’ve got a common strategy, a fantastic global brand and have a real focus on what we’re good at. We should never be complacent, but we’ll succeed with partnership working. I think we should also look at Greater Manchester as a coalition opportunity rather than a competitor, and similarly with London.”

Colin Sinclair concluded: “This is just the start. I’ve seen massive change already since we created the Knowledge Quarter Liverpool innovation district in 2016 and I know this progress will continue, thanks to the people in this room and our wider partnerships.”

KQ Startup launched to support budding entrepreneurs

The new programme will support the growing number of startups and spin-outs created within the Knowledge Quarter Liverpool (KQ Liverpool) innovation district.

Launched today at Liverpool Science Park, KQ Startup is the latest addition to KQ Liverpool’s suite of Innovation and Growth Services, having been specifically designed to help budding entrepreneurs navigate through the early stages of their business journey.

The free to access programme will ensure eligible startups and spin-outs are connected directly with the right people, places and spaces needed to launch successfully in the market, and avoid critical stumbling blocks. 

Colin Sinclair, CEO of KQ Liverpool, said:

“By removing barriers to entry, we can boost the number of new local founders, as well as the success rate of existing startups, which in turn will add to the economic prosperity of our innovation district.

“With world-leading academic institutions and an established culture of entrepreneurialism within our innovation district, KQ Startup will ensure that the groundbreaking ideas and creative research being uncovered on our doorstep can succeed commercially and develop into thriving, scaling businesses.”

KQ Startup has enlisted the support of eight local organisations, who will be offering programme participants complimentary access to a range of bespoke advice and guidance. This includes one to one consultations, digital resources and expert masterclasses across the fields of compliance, marketing, banking and finance, and intellectual property, as well as providing discounted workspaces and networking opportunities. 

The eight KQ Startup Expert Advisors are Dearbridge, List & Found, Lloyds Bank, Marks & Clerk, Moore Media, Sciontec, Sedulo and Typocom.

Rachael Stevens, Head of Partnerships and External Relations at KQ Liverpool, added:

“Navigating the red tape around starting a new business can be both daunting and distracting from the excitement of launching a new product or service. 

“Through KQ Startup, we want to simplify this process and take some of the burden away from founders, therefore enabling business owners to focus on building their teams, attract customers and grow their business.”

KQ Liverpool will also be signposting KQ Startup participants to a number of other local organisations who provide complimentary support to entrepreneurs and SME leaders in the Liverpool City Region. This includes The Brett Centre for Entrepreneurship, The Women’s Organisation, Growth Platform, LYVA Labs, River Capital and the LCR Finance Hub. 

Through collaboration, partnerships and facilitated introductions, KQ Liverpool hopes to engage with around 20 KQ Startup participants across the next 12 months, and deliver new job opportunities, grow the dynamic business community and provide support for all, in line with their inclusive innovation agenda.

To find out more about the KQ Startup programme, Expert Advisors and proven success stories, please download the KQ Startup brochure here.

iiCON strengthens team following ongoing growth

iiCON, led by Liverpool School of Tropical Medicine (LSTM), is comprised of partners Unilever, Liverpool University Hospitals Foundation Trust, University of Liverpool, LifeArc, Evotec, and Infex Therapeutics.

The c£250 million programme brings together industry, academia, and clinicians to accelerate the discovery, development and deployment of new treatments and innovations– saving and improving millions of lives globally through collaborative innovation.

Following the ongoing growth of the programme, iiCON has appointed a new Senior Programme Manager, Gillian Kyalo, who works closely with iiCON’s founding Director Professor Janet Hemingway to oversee and support the smooth running of the programme. Gillian brings over 20 years’ experience managing complex global International Public Health projects for international consortia and organisations including the United Nations, the European Union, UK Research Councils, and the Bill and Melinda Gates Foundation.

The consortium has also welcomed a new Business Development Manager, Dr Lizzie Crawford, who will focus on fostering strategic relationships and driving commercial partnerships for translational research. Lizzie will work with iiCON’s business development team to engage with companies looking to connect into iiCON’s platforms to support their research and development needs.

With a strong scientific background as a pharmacologist and a Ph.D in molecular and cell biology, Lizzie also has experience in the pharmaceutical and biotechnology industries. She spent nine years in technology transfer at the University of Manchester playing a pivotal role in supporting translational research, facilitating licence negotiations and establishing successful spin-out companies. Her expertise spans the full lifecycle of research projects from inception to licence agreements within the complex landscape of academia-industry collaborations. Lizzie is also the founder of a digital health spin out company, with experience across all aspects of the start-up process, including business planning, fundraising, partnership development and regulatory planning, providing a solid understanding of the entrepreneurial ecosystem.

iiCON has also strengthened its core team, welcoming a new finance manager, Lauren Thistlethwaite; programme manager Rose Lopeman; project administrators, Amy Collins, and Alexandra Pendleton; data analyst Jolene Dunlop, and senior finance business partner Laura Carney, to support operational activity across the dynamic consortium, which operates across ten platforms of activity.

Professor Janet Hemingway, founding Director of iiCON, said:

“We’re very pleased to have welcomed a number of new faces to the iiCON team, each one bringing particular skills and expertise.

“As iiCON continues to attract investment and expand activity across our platforms, the complementary experience and specialist sector knowledge within our team means we are well equipped to continue to develop and support long-lasting strategic commercial partnerships; collaborating effectively with diverse stakeholder groups to drive forward the programme – enabling world-leading infection R&D.”

Paddington Community Diagnostic Centre opens to patients

Thousands set to benefit from faster access to vital NHS tests as new Paddington Community Diagnostic Centre opens to patients

People in Liverpool will now benefit from faster access to vital tests and scans for a wide range of health conditions, with the opening of a new NHS community diagnostic centre on the Paddington Village development in Edge Hill.

The new Paddington Community Diagnostic Centre offers tests to people referred by health professionals to check for a wide range of conditions including musculoskeletal problems, gastrointestinal conditions, lung conditions and cancer. It will help them get a confirmed diagnosis so they can begin the treatment they need or to get the all-clear, putting their minds at rest.

The centre is just the first phase of a wider development transforming what was previously the privately-run Rutherford Cancer Centre North West into a first-class NHS facility for the people of Cheshire and Merseyside. In a landmark agreement in March 2023, The Clatterbridge Cancer Centre NHS Foundation Trust acquired the building on behalf of the NHS in our region.

Initially, Paddington Community Diagnostic Centre will offer MRI and ultrasound scans as well as blood tests (phlebotomy). That will extend to CT scans from the autumn once a new scanner has been installed and commissioned. Future phases will see it expand with additional services, further boosting NHS diagnostic capacity in response to local demand.

Community diagnostic centres (CDCs) provide the NHS with additional capacity to carry out vital tests and scans in locations away from the pressures of a busy acute hospital providing emergency care.

Paddington Community Diagnostic Centre is the eighth CDC to open in Cheshire and Merseyside, which has been at the vanguard of rolling out the new centres as part of a national NHS England programme supported by government funding.

St Helens was the first CDC to open nationally, closely followed by Clatterbridge Diagnostics in Wirral. Cheshire and Merseyside now has CDCs in Ellesmere Port, Liverpool Women’s, Northwich, Southport and Halton, with two more on the way: one in Congleton and one at Shopping City in Runcorn.

Together, the new CDCs in Cheshire and Merseyside have already delivered 250,000 additional tests and scans for the NHS than would have been possible without them – a figure that will rise to 318,000 in 2023/24. That’s important because demand has grown year on year.

The number of diagnostic tests performed now is double what it was five years ago, with more than 100,000 carried out each month in Cheshire and Merseyside and demand keeps rising. It means CDCs are an essential tool in cutting waiting times and supporting earlier, faster diagnosis. 

Dr Liz Bishop, Chief Executive of The Clatterbridge Cancer Centre NHS Foundation Trust and Senior Responsible Officer for Diagnostics in Cheshire and Merseyside, said: 

“People in Liverpool are more likely to experience ill health than the national average so it’s particularly important that they can get the tests they need when symptoms develop.

“Faster and earlier access to tests thanks to community diagnostic centres like this will mean people with potentially serious conditions – and those living with pain or other symptoms – can get diagnosed and start treatment more quickly, giving them a better quality of life and a better chance of a successful outcome.

“Paddington Community Diagnostic Centre will help people with many different kinds of health conditions and we feel a real responsibility as a leading specialist trust to develop services like this that support the wider NHS and the communities we serve across Cheshire and Merseyside.”

Dr Michael Gregory, Regional Medical Director at NHS England – North West, said:

“We know that rapid diagnosis saves lives, and the opening of this new facility at the Paddington Village will mean thousands more patients can get life-saving tests, checks and scans in the heart of the community, without having to travel to the hospital.

“This new community diagnostics centre will help address disparities in health within the wider community and decrease the demand for referrals and hospital visits, easing the pressure on hospital facilities.

“It is another fantastic step to ensure that the NHS is making a positive difference to the way the people of Liverpool and beyond receive care.”

Professor Rowan Pritchard Jones, Medical Director for NHS Cheshire and Merseyside, said:

“We are one of the few health systems in the country to have a dedicated programme to improve diagnostics and we welcome the opening of this additional Community Diagnostics Centre for Cheshire and Merseyside as part of that work, helping us to give patients much quicker access to the tests and scans they need. We know that diagnosing patients as soon as possible can lead to better treatment outcomes, which is why centres like this one in Paddington Village are so important.”

Tracey Cole, Diagnostics Programme Director for NHS Cheshire and Merseyside, said:

“Excellent healthcare can only be provided once a patient has a diagnosis. Paddington Community Diagnostic Centre will help ensure that everyone in Cheshire and Merseyside has fast access to the tests they need in a setting local to them. Paddington Community Diagnostic Centre will see all types of patients, not just those who could have cancer. We want patients who are offered an appointment to take up their offer so that we can either rule out anything to be concerned about or be offered treatment if it is required.”

About The Clatterbridge Cancer Centre

The Clatterbridge Cancer Centre NHS Foundation Trust is one of the UK’s leading cancer centres, serving a population of 2.4m in Cheshire & Merseyside and surrounding areas including the Isle of Man and parts of Lancashire.

We provide highly-specialist services including pioneering chemotherapy, immunotherapy and radiotherapy. Our unique networked model includes three Clatterbridge Cancer Centres (Liverpool, Wirral and Aintree), Clatterbridge clinics in other hospitals, and our multi-award-winning Clatterbridge in the Community service treating patients at home.

Our flagship Liverpool hospital opened in June 2020 with state-of-the-art facilities including 110 individual inpatient rooms, stem cell transplant, radiology, a Teenage & Young Adult Unit, clinical therapies, and a wide range of cancer information and support.

We are also a leading research centre with an extensive portfolio of clinical trials including early phase and first-in-human (Phase 1). We are part of Liverpool ECMC (experimental cancer medicine centre), a Biomedical Research Centre with The Royal Marsden, and Liverpool CRF (clinical research facility).

About CDCs in Cheshire and Merseyside

Eight community diagnostic centres (CDCs) have now opened in Cheshire and Merseyside since the programme launched in 2021:

  • Ellesmere Port – Ellesmere Port Hospital (run by Countess of Chester Hospital)
  • Liverpool – Liverpool Women’s Hospital (run by Liverpool Women’s)
  • Northwich – Victoria Infirmary (run by Mid Cheshire Hospitals)
  • Paddington – Paddington Village (run by The Clatterbridge Cancer Centre)
  • Runcorn – Halton Hospital (run by Warrington and Halton Hospitals)
  • Southport – Southport Hospital (run by Mersey and West Lancashire Teaching Hospitals)
  • St Helens – St Helens Hospital (run by Mersey and West Lancashire Teaching Hospitals)
  • Wirral – Clatterbridge (run by a partnership between The Clatterbridge Cancer Centre and Wirral University Teaching Hospital)

Two more are due to open by the end of 2023/24: one in Congleton and one at Shopping City in Runcorn.

LCR announced as the UK’s second Investment Zone

  • The Liverpool City Region has been unveiled as England’s second Investment Zone, focused on Life Sciences 
  • Sites in Halton, Knowsley, Liverpool, Sefton and St Helens could be set to benefit from £310m of private investment and more than 4,000 new jobs over the next five years. 
  • An initial £10m from a US pharmaceutical company to enhance its capabilities in manufacturing a drug used to treat cancers, arthritis and skin conditions 

Communities across the Liverpool City Region could be set to benefit from over 4,000 new jobs and a multi-million-pound investment in the life sciences sector as part of the UK’s second Investment Zone. 

The government has today (26 July 2023) launched England’s second Investment Zone in Liverpool City Region, which could unlock £320 million of private investment and deliver 4,000 jobs, across the Liverpool City Region over the next 5 years. 

An initial £10 million investment will be made by US pharmaceutical manufacturer TriRx, to enhance its capabilities to manufacture monoclonal antibodies, a type of immunotherapy that work by blocking certain diseases from affecting healthy cells and are used to treat numerous types of diseases including cancers, arthritis and skin conditions. 

This investment in the city region’s existing Speke Pharma cluster – home to one of the UK’s leading regions for bioprocessing – is the first step in unlocking a total pipeline up to £320 million of further private funding from a range of investors in the life sciences sector, helping to deliver over 4,000 jobs in the region over the next 5 years. 

Backed by £80 million in government funding, the Investment Zone will benefit from a range of interventions which could include skills, infrastructure and tax reliefs, depending on local circumstances – with the potential to make the Liverpool City Region a pharmaceutical production superpower. 

The health and life sciences sector already contributes an estimated £290m to the Liverpool City Region’s economy every year and Mayor Rotheram, has an ambitious target to invest 5% of its GVA to research and development – almost double the national target. 

Mayor Steve Rotheram, the Liverpool City Region Combined Authority, regional universities and other local partners will continue to work with the government to co-develop the plans for their Life Sciences Investment Zone, including agreeing priority development sites and specific interventions to drive cluster growth, over the summer, ahead of final confirmation of plans. 

Steve Rotheram, Mayor of the Liverpool City Region, said:  

“Our area is fortunate to play home to world-leading clusters in life science research and innovation, which support thousands of secure, well-paid jobs and training opportunities for local people. I am incredibly proud of what our region has achieved in the sector – but this is just a down payment on my future ambitions. I want us to go even further and establish our region at the forefront of UK science and innovation.

“With a potential £310m worth of investment and thousands of local jobs on offer, it is clear that this is an opportunity worth exploring. Yet, throughout this process, I have been clear that any investment in our area must go much further than purely financial incentives. I want to use our status as a force for good, to connect our residents up to secure, well-paid jobs and training opportunities, and attract transformational investment into our area.

“To play our part in making that happen, we will be investing 5% of GVA in R&D over the next few years – that is nearly double national targets. Becoming an innovation superpower  might sound like a lofty ambition – but I believe that if anywhere has the potential to achieve it, then it’s the Liverpool City Region.”

Mark Proctor, AstraZeneca Site Lead for Speke said: 

“AstraZeneca welcomes the establishment of the Liverpool City Region Investment Zone focussed on life sciences, which has the potential to attract more businesses to the region’s already thriving medicine development and manufacturing cluster.

We employ 400 people at our site in Speke to manufacture our intranasal influenza vaccine, used in the UK for the child and adolescent immunisation programme and exported to markets around the world.

The site has the potential to expand into new technology platforms for vaccines and we look forward to working with the Liverpool City Region to identify opportunities to develop these capabilities in the coming years.”

Tim Tyson, Chairman and CEO of TriRx, said: 

“We are delighted to be expanding our capability in this critical immunotherapy area, to become a worldwide centre of technical excellence located in the UK in the monoclonal antibody development and manufacturing field to serve the human and animal pharmaceutical markets”.

The Liverpool City Region Life Sciences Investment Zone will be developed alongside the city region’s freeport, which became operational earlier this year. 

By grouping high-productivity and innovative businesses close together, the freeport can play a role in the region’s work to tackle the underlying weaknesses in the local job market such as productivity, pay and job security. 

The region’s leaders have chosen to pursue businesses and industries that align with the values and priorities of the Combined Authority. These include innovation in advanced manufacturing, pharmaceuticals and green energy – with a particular focus on the region’s target to be net zero carbon by 2040 at the latest and protections in place for both environmental standards and workers’ rights.